PAVmed Inc. (NASDAQ:PAVM) Q3 2022 Earnings Conference Call November 15, 2022 4:30 PM ET

Company Participants

Adrian Miller - VP, IR

Lishan Aklog - Chairman and CEO

Dennis McGrath - President and CFO

Conference Call Participants

Charlie Montang - Lake Street Capital Markets

Edward Woo - Ascending Capital Markets LLC

Anthony Vendetti - Maxim Group

Operator

Ladies and gentlemen, greetings and welcome to the PAVmed Inc. Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host Adrian Miller, Vice President of Investor Relations. Please go ahead.

Adrian Miller

Thank you, operator. Good afternoon, everyone. This is Adrian Miller, Vice President of Investor Relations at PAVmed. Thank you for participating in today's business update call.

Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer of PAVmed, along with Dennis McGrath, President and Chief Financial Officer of PAVmed.

The press release announcing our business updates and financial results is available on PAVmed's Web site. Please take a moment to read the disclaimer about forward-looking statements in the press release. The business update press release and this conference call, both include forward-looking statements and these forward-looking statements are subject to known and unknown risks and uncertainties, that may cause actual results to differ materially from statements made.

Factors that could cause actual results to differ are described in the disclaimer and in our filings with the SEC. For a list and description of these and other important risks and uncertainties that may affect future operations, see Part 1, Item 1A entitled Risk Factors in PAVmed's most recent annual report on Form 10-Q filed with the SEC and subsequent updates filed in quarterly reports on Form 10-Q and in subsequent Form 8-K filing.

Except as required by law, PAVmed disclaims any intentions or obligations to publicly update or revise any forward-looking statements to reflect changes in expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.

With that, I'd like to turn the call over to Lishan Aklog. Dr. Aklog?

Lishan Aklog

Thanks, Adrian and thank you all. Good afternoon for joining us on this PAVmed's quarterly update call. I would like to first start by thanking our long-term shareholders for their ongoing commitment and support. You'll note that this quarter, we're using a new format with a webcast in response to feedback, including one of our long-term investors in Boston. We're really happy that we've done this. So far, the feedback from the recent webcast yesterday has been uniformly positive.